Palatin Technologies Inc (NYSE MKT LLC:PTN)

0.861
Data as of 11:30am ET
 -0.029 / -3.26%
Today’s Change
0.56
Today|||52-Week Range
1.50
+17.30%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$35.1M

Company Description

Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. It programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. The company's primary product in development is bremelanotide for the treatment of female sexual dysfunction. It is also developing an inhalation formulation of peptide mimetic natriuretic peptide receptor A-agonist, for treatment of cardiovascular and pulmonary indications. The company was founded by Carl Spana and John K. A. Prendergast in 1986 and is headquartered in Cranbury, NJ.

Contact Information

Palatin Technologies, Inc.
Cedar Brook Corporate Center
Cranbury New Jersey 08512
P:(609) 495-2200
Investor Relations:

Employees

Shareholders

Mutual fund holders4.02%
Other institutional21.37%
Individual stakeholders16.70%

Top Executives

Carl SpanaPresident, Chief Executive Officer & Director
Stephen T. WillsCOO, CFO, Secretary, Treasurer & Executive VP
Jeff D. EdelsonChief Medical Officer
Stephen A. SlusherChief Legal Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.